Opthea Ltd
CKDXF · OTCMCIK 1815620fmd_15C0WKK4ZGF9J4Q79BTYVVHXDQManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jul 01, 2018 to Jun 30, 2025, 9 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Research and development | 22 | 12 | 26 | 81 | 129 | 176 | 127 |
| Operating income | – | – | – | (97) | (150) | (192) | (156) |
| Interest expense | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before taxes | (25) | (17) | (50) | (99) | (148) | (230) | (170) |
| Income tax expense | (10) | (6) | (5) | (6) | (6) | (9) | (7) |
| Net income from continuing operations | (15) | (11) | (45) | (93) | (143) | (220) | (163) |
| Net income | (15) | (11) | (45) | (93) | (143) | (220) | (163) |
| Net income to common shareholders | (15) | (11) | (45) | (93) | (143) | – | – |